Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders

Cardiovascular Survey Methods.

Geoffrey Rose, H Blackburn · Annals of Internal Medicine · 1968 · 3.1K citations

Public Health, Cardiology, Health Sciences +8

VLDL, Apolipoproteins B, CIII, and E, and Risk of Recurrent Coronary Events in the Cholesterol and Recurrent Events (CARE) Trial

Frank M. Sacks, Petar Alaupovic, Lemuel A. Moyé et al. · Circulation · 2000 · 490 citations · Full text

Medicine, Cardiology, Pharmacology +17

Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.

C S Wang, Walter J. McConathy, H. U. Kloer et al. · Journal of Clinical Investigation · 1985 · 415 citations · Full text

Life Sciences, Biochemistry, Nutritional Sciences +14

Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates.

Bart Staels, Ngoc Vu‐Dac, V. A. Kosykh et al. · Journal of Clinical Investigation · 1995 · 409 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels—a prospective and cross-sectional evaluation

Altan Onat, Köksal Ceyhan, Ömer Başar et al. · Atherosclerosis · 2002 · 316 citations

Medicine, Cardiology, Endocrinology +17